IMB Centre for Pain Research

Dr Hana Starobova's research focuses on relieving children from chemo side-effects which can last into adulthood.

IMB researchers have found that the New Zealand stinging tree produces toxins that could hold clues for future pain medication.

Australian bull ants have evolved a venom molecule that has implications for sufferers of long-term pain.

Drug discovery research at IMB has been given a $12.9 million boost of Australian Government funding, to push the boundaries for more targeted, efficient new medicines.

Researchers are daring to discover urgently needed new drugs and therapies from one of the most painful plants in Australia.

Chronic pain is a life-altering condition, but the answer to this devastating condition could come from an animal with a deadly sting.

Associate Professor Markus Muttenthaler has been awarded an Australian Research Council (ARC) Future Fellowship.

The side effects of the chemotherapy have been reduced by an anti-inflammatory drug.

IMB researchers are carrying out genome sequencing to provide clues as to why jellyfish venoms are so deadly.

Venom from spitting cobras has evolved as a form of self-defence, rather than for capturing prey, and is more effective at causing pain than venom from non-spitters.